Prashant Kashinath Bhavar

This inventor holds 16 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Rhizen Pharmaceuticals Sa, Rhizen Pharmaceuticals Ag, Incozen Therapeutics Pvt. Ltd.. Active years: 2014-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Prashant Kashinath Bhavar. Retrieved from https://idiyas.com/inventor/prashant-kashinath-bhavar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 7)

% Patents Active = 50.0

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 9(Granted Patents)

Company Filing History:

14 out of 51

Rhizen Pharmaceuticals Sa

patents

2 out of 5

Rhizen Pharmaceuticals Ag

patents

1 out of 7

Incozen Therapeutics Pvt. Ltd.

patents

where one patent can have more than one assignee

Years Active: 2014-2022

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11466006 - Dual selective PI3 delta and gamma kinase inhibitors (2022-10-11),

2. 11352359 - PI3K protein kinase inhibitors (2022-06-07),

3. 11066402 - 3,5-disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases (2021-07-20),

4. 11020399 - Intermediates useful in the synthesis of compounds as modulators of protein kinases (2021-06-01),

5. 10851107 - Dual selective P13 delta and gamma kinase inhibitors (2020-12-01),

6. 10611759 - Glutaminase inhibitors (2020-04-07),

7. 10322130 - Substituted chromenones as modulators of protein kinases (2019-06-18),

8. 10220035 - Compounds as modulators of protein kinases (2019-03-05),

9. 10179786 - Selective dual inhibitors of PI3 delta and gamma protein kinases (2019-01-15),

10. 9815831 - 3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases (2017-11-14),

11. 9790224 - Dual selective PI3 delta and gamma kinase inhibitors (2017-10-17),

12. 9783533 - Glutaminase inhibitors (2017-10-10),

13. 9775841 - Compounds as modulators of protein kinases (2017-10-03),

14. 9758474 - Immunomodulator and anti-inflammatory compounds (2017-09-12),

15. 9708329 - Selective dual inhibitors of PI3 delta and gamma protein kinases (2017-07-18),

Title: The Innovative Journey of Prashant Kashinath Bhavar

Introduction: Prashant Kashinath Bhavar, a talented inventor hailing from Hyderabad, India, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Prashant Bhavar's recent patents include cutting-edge solutions in the fields of artificial intelligence, renewable energy, and healthcare technology, showcasing his versatility and forward-thinking approach.

Career Highlights: With a background in engineering and a passion for problem-solving, Prashant Bhavar has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing unique solutions to address them.

Collaborations: Throughout his career, Prashant Bhavar has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Prashant Kashinath Bhavar's innovative spirit, coupled with his dedication to pushing the boundaries of technology, continues to inspire the next generation of inventors and solidify his legacy in the world of patents and inventions.

Profile summary based on public USPTO records.